Yunus Moosa

University of KwaZulu-Natal - Department of Infectious Diseases

Durban, 4420

SCHOLARLY PAPERS

2

DOWNLOADS

37

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Comparing Effectiveness of First-Line Antiretroviral Therapy between Peri-Urban and Rural Clinics in KwaZulu-Natal, South Africa

Number of pages: 31 Posted: 28 May 2021
Jaysingh Brijkumar, J. Edwards, B. A. Johnson, Claudia Ordonez, Henry Sunpath, M. Lee, Mathew Dudgeon, Lydia Rautman, Selvan Pillay, Pravi Moodley, Y. V. Sun, Jose Castillo-Mancilla, Jonothan Li, D. K. Kuritzkes, Yunus Moosa and Vincent C. Marconi
University of KwaZulu-Natal - Nelson R Mandela School of Medicine, Emory University - Rollins School of Public Health, University of Rochester, Emory University - School of Medicine, University of Kwazulu-Natal, Emory University - Rollins School of Public Health, Emory University - School of Medicine, Emory University - School of Medicine, University of Kwazulu-Natal, University of Kwazulu-Natal, Emory University - Rollins School of Public Health, University of Colorado, Aurora - Anschutz Medical Campus, Harvard University - Harvard Medical School, Harvard University - Brigham and Women's Hospital, University of KwaZulu-Natal - Department of Infectious Diseases and Emory University - Rollins School of Public Health
Downloads 21 (1,122,824)

Abstract:

Loading...

Virologic failure, virologic suppression, clinic retention, drug resistance, 95-95-95

2.

Divergence of Delta and Beta Variants and SARS-CoV-2 Evolved in Advanced HIV Disease into Two Serological Phenotypes

Number of pages: 25 Posted: 11 Oct 2021
Sandile Cele, Farina Karim, Gila Lustig, James Emmanuel San, Tandile Hermanus, Eduan Wilkinson, Jumari Snyman, Mallory Bernstein, Khadija Khan, Shi-Hsia Hwa, Houriiyah Tegally, Sasha W. Tilles, Lavanya Singh, Jennifer Giandhari, Ntombifuthi Mthabela, Matilda Mazibuko, Yashica Ganga, Bernadett I. Gosnell, Salim Abdool Karim, Willem Hanekom, Wesley C. Van Voorhis, Thumbi Ndung’u, COMMIT-KZN Team, Richard Lessells, Penny L. Moore, Yunus Moosa, Tulio de Oliveira and Alex Sigal
Africa Health Research Institute, Africa Health Research Institute, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, National Institute for Communicable Diseases of the National Health Laboratory Service, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, University of Washington, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, Africa Health Research Institute, Africa Health Research Institute, Africa Health Research Institute, University of KwaZulu-Natal - Department of Infectious Diseases, University of KwaZulu-Natal - Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of Cape Town (UCT) - South African Tuberculosis Vaccine Initiative, University of Washington, Africa Health Research Institute, affiliation not provided to SSRN, University of KwaZulu-Natal - School of Laboratory Medicine and Medical Sciences, University of the Witwatersrand, University of KwaZulu-Natal - Department of Infectious Diseases, University of KwaZulu-Natal - School of Laboratory Medicine and Medical Sciences and Africa Health Research Institute
Downloads 16 (1,185,169)
Citation 1

Abstract:

Loading...

SARS-CoV-2, Neutralization, Serotypes, Beta variant, Delta variant, SARS-CoV-2 evolution, Advanced HIV disease